在急性心力衰竭中对胸腔进行随机对照试验
Signe Glargaard1, Jakob Hartvig Thomsen1,2, Christian Tuxen1
1Department of Cardiology, Copenhagen University Hospital-Bispebjerg and Frederiksberg, Denmark (S.G., J.H.T., C.T., J.J.T.).
Circulation
|April 1, 2025
概括
在急性心力衰竭和多流的患者中,前期胸腔注射没有改善结果. 与标准护理相比,TAP-IT试验没有发现出院存活日数或死亡率的显著差异.
科学领域:
- 心脏病学
- 肺病学
- 干预心脏病学
背景情况:
- 急性心力衰竭通常表现为肺部溢出,影响患者的预后.
- 治疗胸腔切除是治疗这些溢出的一种潜在干预措施.
研究的目的:
- 在急性心力衰竭患者中,评估前期胸腔结合标准治疗的疗效.
- 确定这种策略是否与单独的标准治疗相比改善了关键的临床结果.
主要方法:
- 这是一项多中心随机对照试验 (TAP- IT),涉及135名急性心力衰竭和多流的患者.
- 患者被随机分为超声导向胸腔切除加标准治疗或单独标准治疗.
- 主要结局是出院90天;次要结局包括住院时间和死亡率.
主要成果:
- 胸腔切除和对照组的90天生存时间没有显著差异 (中位数为84天与82天,P=0. 42).
- 这两组的90天全因死亡率为13%,生存概率没有差异 (P=0. 90).
- 在医院住院时间上没有显著差异.
结论:
- 在急性心力衰竭和多流的患者中,除了标准的药物治疗外,前期胸腔切除并没有改善90天的结果.
- 这些发现表明,在这种患者群体中,常规胸腔切除可能没有益处.
- 需要进一步的研究来证实这些结果并探索最佳的管理策略.
更多相关视频
05:50International Expert Consensus and Recommendations for Neonatal Pneumothorax Ultrasound Diagnosis and Ultrasound-guided Thoracentesis Procedure
Published on: March 12, 2020
13.2K
08:50Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
Published on: March 26, 2018
11.6K
相关概念视频
Endoscopic Studies II: Thoracocentesis
178
Thoracentesis(Thoracocentesis), commonly known as pleural tap, is a medical procedure where a 22 gauge needle is inserted into the pleural space, the area between the lung and chest wall. This procedure is commonly performed to diagnose or treat various respiratory disorders.
Description
Excess pleural fluid or air may accumulate in some respiratory disorders in the thoracic cavity. To treat pleural effusion, a physician conducts thoracentesis by carefully piercing the chest wall and entering...
Description
Excess pleural fluid or air may accumulate in some respiratory disorders in the thoracic cavity. To treat pleural effusion, a physician conducts thoracentesis by carefully piercing the chest wall and entering...
178
Pneumothorax-II
110
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
110
Acute Respiratory Failure-V
113
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
113
Pneumothorax-I
161
A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
161
Flail Chest-II
148
Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
Assessment:
1. Clinical Evaluation:
History:
148
